Note: a very disgusting news story. Alan
Recent breakthroughs in the field of genetic editing have caused a great deal of debate between proponents of the technology who think it can cure many diseases and alleviate human suffering on a scale never before seen and skeptics of the technology who believe that genetic editing is an instance of man playing God and could have terrible unintended consequences.
Another voice has put themselves into the center of the debate: Goldman Sachs. The multinational banking giant warned that genetic editing technology curing many diseases could be bad for business.
According to a CNBC report, Goldman Sachs analysts asked the following question in an Apr. 10 report released to shareholders: “Is curing patients a sustainable business model?”